Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Milestone Pharmaceuticals granted 123,000 stock options to new employees as inducements under its 2021 Inducement Plan, with options priced at the April 1, 2026 closing price of $1.31 per share. The options vest over four years contingent on continued service, aligning with Nasdaq Listing Rule 5635(c)(4). Milestone focuses on developing cardiovascu…